Labor Market Pulse ArchiveSubscribe to a report

Labor Market Pulse · Life Sciences · October 2026

Life Sciences Labor Market Report: Burlington, NC MSA — October 2026

Burlington life sci pay outpaces national trend on regulatory, clinical roles.

Burlington's Regulatory Affairs pay hit $119,186, 15% above the $103,780 national median, as nearby biomanufacturing expansion from Amgen and J&J tightens the regional talent pool despite the metro's modest net job losses.

Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.

Key indicators

  • Burlington MSA unemployment: 3.8% — vs 4.1% national, 3.4% NC (Aug 2026)
  • Burlington average monthly job change: -50 jobs/mo — 5th-worst metro job growth in NC, 2026
  • Regulatory Affairs pay, metro vs national: $119,186 vs $103,780 — Metro up significantly, national down moderately
  • NC biopharma manufacturing workforce need: 8,000+ workers — Needed by 2026 per NCBiotech

Key takeaways

Regulatory Affairs pay has decoupled from the national trend.

Metro advertised pay for Regulatory Affairs Specialists rose significantly to $119,186 while the national median fell 103,780 and declined moderately. Local demand, likely driven by nearby biomanufacturing expansion, is outpacing national softening — a signal to benchmark this role against local data.

CRA pay gains point to a bottleneck.

Metro Clinical Research Associate pay rose significantly to $94,581, above the national median of $90,065, while national quit rates sit near 1.9%. Experienced CRAs are staying put industry-wide, so upward local pay movement likely reflects employers paying premiums to pull talent from a limited pool.

Biostatistician premiums outstrip national flatness.

Metro Biostatistician pay climbed moderately to $140,326 against a stable national median of $131,958. Wage growth concentrated in a high-credential analytical role is consistent with statewide data showing upper-half earners capturing most 2026 wage gains, while entry-level and support roles stagnate.

Net job losses mask a credential-driven talent squeeze.

Burlington lost roughly 50 jobs per month on average through mid-2026 even as unemployment held near 3.8%, well below the national 4.1% rate. Headline job counts understate the difficulty of filling specialized R&D, quality and regulatory roles when overall employment is contracting but skilled talent remains scarce.

Median advertised pay by role — Burlington, NC MSA

Life Sciences roles, October 2026. Source: WageScape.
Role25th percentileMedian advertised pay75th percentileMetro trendNational median
Research Scientist *$97,051$123,500$132,756Moderate increase$130,339
Clinical Research Associate *$61,795$94,581$112,500Significant increase$90,065
Lab Technician$41,303$44,208$44,548Significant increase$47,840
Regulatory Affairs Specialist *$78,659$119,186$119,783Significant increase$103,780
Clinical Data Manager *$98,797$118,202$121,795Stable$123,653
Biostatistician *$112,797$140,326$160,630Moderate increase$131,958
Validation Engineer *$88,997$96,700$107,123Stable$106,478

* State-level figure shown where metro postings were too few.

WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON

Local market conditions

Burlington MSA unemployment held at 3.8% in August against a state rate of 3.4%, reflecting a metro labor market tighter than its net job losses suggest — the area shed an average of 50 jobs monthly through mid-2026 even as the labor pool stayed fully utilized. State-level manufacturing capacity expansion, including Amgen's 370-job Holly Springs buildout and J&J's $2B Wilson County campus, is pulling specialized quality and manufacturing talent toward larger in-state employers, tightening the pool available to smaller Burlington-area life sci operations.

What it means

Scale-ups at Amgen and J&J signal that build-vs-outsource calculus is shifting: as incumbents expand in-state biologics and pharmaceutical manufacturing, CDMO capacity becomes harder to secure and in-house hiring for quality, CMC and clinical operations roles carries more urgency than it did a year ago. Metro advertised pay for Regulatory Affairs Specialists ($119,186) now runs 15% above the national median ($103,780), consistent with Burlington-area employers competing directly against Research Triangle biomanufacturing投资 for the same credentialed talent pool. Organizations should evaluate whether current regulatory and CMC compensation bands reflect this emerging in-state competition and update historical regional benchmarks accordingly.

Looking ahead

Potential inflection point: Amgen's Holly Springs expansion and J&J's Wilson County campus are scheduled to ramp hiring through 2026 and into 2027. Watch whether Burlington-area manufacturing and quality staff begin commuting or relocating toward these larger projects, thinning the local talent pool further.

Worth watching: NC's biopharmaceutical manufacturing sector needs 8,000+ workers by 2026, but the accessible entry pathways NCBiotech highlights address production roles and leave career-stage regulatory or CMC talent needs unmet. Expect continued upward pressure on advertised pay for credentialed roles even as entry-level manufacturing hiring stays active.

Early indicator: State WARN filings show healthcare and manufacturing layoffs rising (13 and 34 notices respectively in the past 90 days), though none yet reported in Burlington specifically. Monitor whether displaced talent from nearby counties begins surfacing in the Burlington candidate pool, which could ease pressure on technician and support roles.

Emerging pressure point: Lab/R&D vacancy reached 23.2% nationally in Q1 2026, and Burlington's Lab Technician pay — measured by job ads, which track hiring demand and often cover several openings each — rose significantly to $44,208 even as the national figure held stable. Sustained local wage movement in an entry-tier role is consistent with employers reaching deeper into adjacent labor pools to backfill scientific support staff.

Sources

  1. NC Department of Commerce — Burlington MSA unemployment rate at 3.8% in August 2026
  2. USA Facts/BLS Employment Data — Burlington lost average of 50 jobs monthly through mid-2026
  3. NC Life Sciences economic development reporting — Amgen 370-job expansion, $1B investment in Holly Springs
  4. NC Life Sciences economic development reporting — J&J 420-job, $2B pharmaceutical campus in Wilson County
  5. Biopharma labor market survey data — National quit rate at 1.9% signals constrained candidate movement
  6. NC Biotechnology Center (NCBiotech) — NC biopharmaceutical manufacturing needs 8,000+ workers by 2026

Methodology

Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.

Free to read and cite with attribution to WageScape. Terms of use.